Morgan Stanley Bio Techne Corp Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Bio Techne Corp stock. As of the latest transaction made, Morgan Stanley holds 5,719,540 shares of TECH stock, worth $276 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,719,540
Previous 4,758,525
20.2%
Holding current value
$276 Million
Previous $343 Million
2.16%
% of portfolio
0.02%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding TECH
# of Institutions
627Shares Held
160MCall Options Held
90KPut Options Held
14.2K-
Vanguard Group Inc Valley Forge, PA18.5MShares$895 Million0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$724 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.4MShares$550 Million0.08% of portfolio
-
State Street Corp Boston, MA6.53MShares$315 Million0.02% of portfolio
-
Select Equity Group, L.P. New York, NY5.37MShares$259 Million1.58% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $1.89B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...